ClinicalTrials.gg
CompletedNCT04675164Updated Nov 27, 2023

Laser Assisted Sperm Selection of Viable Immotile Testicular Sperm in Azoospermic Infertile Men

An interventional study of Laser Assisted Immotile Sperm Selection and Hypo-osmotic Swelling Test in Azoospermia and IVF, sponsored by Sohag University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2023-11-27.

Sponsored by Sohag University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
168
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

This study aims to investigate the outcome of ICSI after using LAISS for selection of viable immotile testicular sperm in azoospermic infertile men.

Patients will be randomly assigned to 2 groups. In (LAISS) group, viable immotile testicular sperms will be selected before ICSI using laser assisted immotile sperm selection (study group). In (HOST) group, viable immotile testicular sperms will be selected before ICSI using hypo-osmotic swelling test (control group).

02

Conditions studied

  • Azoospermia
  • IVF

Browse trials for

Keywords

  • Laser Assisted Immotile Sperm Selection
  • Hypo-osmotic swelling test
  • ICSI
  • Testicular sperm
03

In context

Azoospermia

59 studies on the registry are indexed under Azoospermia; 17 are open to participants now.

This study's enrollment of 168 is above the median of 57 across 32 interventional studies indexed under Azoospermia.

Browse Azoospermia studies →

Lead sponsor

Sohag University is the lead sponsor of 1,230 studies on the registry; 636 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Eligible couples are those undergoing ICSI due to azoospermia with testicular positive for sperm (either fresh or cryopreserved) following testicular sperm extraction (TESE) or aspiration (TESA).

Exclusion criteria

Exclusion Criteria:

  • Cases with female factor infertility or woman age above 35 years will be excluded.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Biopsy and archival tissue

A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.

Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
168 participants (actual)

Study arms

  • Active comparator
    LAISS group

    Viable immotile testicular sperms will be selected before ICSI using laser assisted immotile sperm selection (study group).

    Device: Laser Assisted Immotile Sperm Selection

  • Active comparator
    HOST group

    Viable immotile testicular sperms will be selected before ICSI using hypo-osmotic swelling test (control group).

    Procedure: Hypo-osmotic Swelling Test

Interventions

  • DeviceLaser Assisted Immotile Sperm Selection

    LAISS will be performed using diode laser system at the lowest working power with a single laser shot at the lower one third of the sperm tail. If sperm tail curling occurred, the sperm is then viable and will be utilized for ICSI after immobilization in PVP.

  • ProcedureHypo-osmotic Swelling Test

    HOST will be performed by transferring immotile sperms from incubation droplet into HOST droplet, with any sperm showing tail swelling will be identified as viable and will be utilized for ICSI after immediate transfer and immobilization.

06

What researchers measure

Primary outcomes

  1. Clinical pregnancy rate

    Presence of a fetal heartbeat at 6-7 weeks of pregnancy.

    Time frame: 6- 7 weeks

07

Study locations

1 site
  • Ajyal Hospital, IVF Center
    Sohag, 82524, Egypt
08

References and documents

Individual participant data

Plan to share: Yes — Share IPD upon justified request to study director

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: Data shall become permanently available for share in Q3 2022.

Access criteria: Justified request to study director

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 27, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04675164
Lead sponsor
Sohag University
Responsible party
Mohamed Alaa El-Dein Hasan (Assistant Lecturer of Dermatology, Venreology and Andrology, Sohag University) — Principal investigator
First posted
Dec 19, 2020
Start date
Oct 1, 2020
Primary completion
Sep 30, 2023
Completion
Sep 30, 2023
Last update
Nov 27, 2023

Study contacts

Ramadan SA Saleh, MD
study director · Sohag Faculty of Medicine

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion